Find a Commonwealth Resource
Rivastigmine tartrate
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Rivastigmine Tartrate is a generic prescription medication available as oral capsules in strengths of 1.5mg, 3mg, 4.5mg, and 6mg (base equivalent). It acts as a cholinesterase inhibitor to help manage symptoms of Alzheimer's disease and related dementias. Manufactured by Macleods Pharmaceuticals Limited. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Rivastigmine tartrate
Access the FDA dataset for Rivastigmine tartrate — ANDA 077130 submitted by Mylan Institutional LLC
Modified Jul 29, 2026